Subclinical coronary artery disease in COVID-19 patients
Luca Nai Fovino, Filippo Cademartiri, Giuseppe Tarantini
Abstract
Values are mean SD or n (%). The values in bold represent statistical significant differences between groups. ACEi, angiotensin converting-enzyme inhibitor; ARB, angiotensin receptor blocker; CRP, C-reactive protein Hs-Troponin, high
Topics & Concepts
Coronary artery diseaseSubclinical infectionInternal medicineCardiologyCoronavirus disease 2019 (COVID-19)MedicineAngiotensin receptorAngiotensin-converting enzymeC-reactive proteinTroponinDiseaseAngiotensin IIReceptorInflammationMyocardial infarctionBlood pressureInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCardiovascular Disease and AdiposityCardiac Imaging and Diagnostics